カテゴリ： GlobalData, アメリカ, 企業調査

Agilent Technologies Inc (A)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Agilent Technologies Inc (A) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011419
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月22日
◆ページ数：119
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company offers its products to diagnostics, life sciences and applied chemical markets. It serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Agilent Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Agilent Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Inc, Medical Equipment, Deal Details 16
Asset Purchase 16
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 16
Dako To Acquire Intellectual Property Rights From System Dynamics 17
Venture Financing 18
NanoCellect Biomedical Raises USD10 Million in Series B Financing 18
Private Equity 19
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 19
Partnerships 20
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 20
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 21
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 22
Agilent Technologies and Agendia Enter into Agreement 23
Agilent Technologies Enters into Agreement with Burning Rock Biotech 24
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 25
Agilent Technologies Enters into Agreement with Eurofins Genomics 26
Agilent Technologies Enters into Agreement with 10X Genomics 27
Protea Biosciences Enters into Agreement with Agilent Technologies 28
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 29
Merck and Pfizer Enters into Agreement with Dako 30
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 31
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 32
Agilent Extends Co-Marketing Agreement with MRM Proteomics 33
Dako Enters into Agreement with Merck for Companion Diagnostic Test 34
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 35
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 36
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 37
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 38
Agilent Enters Into Research Agreement With Chungnam National University 39
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 40
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 41
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 42
Agilent Technologies Enters Into Research Agreement With Ameritox 43
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 44
Advion Enters Into Technology Integration Agreement With Agilent Technologies 45
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 46
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 47
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 48
Dako Enters Into Co-Development Agreement With Amgen 49
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 50
Dako Enters Into Co-Development Agreement With Amgen 51
Dako Enters Into Co-Development Agreement With Bristol-Myers 52
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 53
Dako Denmark Enters Into Co-Development Agreement With Epitomics 54
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 55
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 56
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 57
Debt Offering 58
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 58
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 59
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 61
Asset Transactions 63
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 63
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 64
Acquisition 65
Agilent Technologies Acquires Multiplicom for USD72 Million 65
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 66
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million 67
Agilent Technologies Acquires Cartagenia for USD68.34 Million 68
Agilent Technologies To Acquire ABC Instrumentacion Analitica 69
Leica Biosystems Completes Acquisition Of Aperio Technologies 70
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 72
Agilent Technologies Completes Acquisition Of BioSystem Development 74
Agilent Technologies Acquires P.V.R. 75
Agilent Technologies Acquires Lab901 76
Agilent Technologies Inc – Key Competitors 78
Agilent Technologies Inc – Key Employees 79
Agilent Technologies Inc – Locations And Subsidiaries 81
Head Office 81
Other Locations & Subsidiaries 81
Recent Developments 83
Strategy And Business Planning 83
Jul 07, 2017: Agilent Technologies Opens New Customer & Technology Center in Waldbronn, Germany 83
Nov 30, 2016: Agilent Technologies Opens Folsom Technology Center 84
Financial Announcements 85
Nov 20, 2017: Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results 85
Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 86
May 22, 2017: Agilent Technologies Reports Second-Quarter Fiscal Year 2017 Financial Results 87
Feb 14, 2017: Agilent Technologies Reports First-Quarter 2017 Results 88
Nov 15, 2016: Agilent Technologies Reports Fourth-Quarter 2016 Results 89
Aug 17, 2016: Agilent Technologies Reports Third-Quarter 2016 Results 90
May 16, 2016: Agilent Technologies Reports Second-Quarter 2016 Results 91
Feb 16, 2016: Agilent Technologies Reports First-Quarter 2016 Results 92
Corporate Communications 93
Jul 18, 2017: Hans E. Bishop to Join Agilent’s Board of Directors 93
May 04, 2017: Agilent Technologies Receives Multiple Awards at Scientific Conference in China 94
Mar 20, 2017: Agilent Technologies Hires Samraat “Sam” Raha to Head Strategy and Corporate Development 95
Mar 15, 2017: Agilent Technologies Board of Directors Elects Koh Boon Hwee as New Chairman 96
Mar 14, 2017: Agilent Technologies Receives 2017 Scientists’ Choice Award for Best Webinar Series 97
Feb 21, 2017: Agilent Technologies Receives Dow’s Western Canada Science and Technical Excellence Conference Awards (WesTEC) for Technical Excellence and Innovation 98
Dec 21, 2016: Agilent Technologies Receives Top Innovation Award from The Analytical Scientist 99
Mar 17, 2016: Agilent Technologies Receives Award for Outstanding Customer Service for Second Straight Year 100
Jan 27, 2016: Agilent Technologies Wins Award for Innovation in Liquid Chromatography 101
Jan 06, 2016: Agilent Technologies Names Michael Tang Senior Vice President, General Counsel and Secretary 102
Legal and Regulatory 103
Jan 11, 2017: Applied Spectral Imaging announced that its GenASIs applications comply with CE-IVD requirements with the IQFISH lung cancer panel on Dako Omnis of Agilent Technologies 103
Jan 06, 2016: ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies 104
Product News 105
Jun 19, 2017: Agilent Technologies Unveils New Analytical and Purification Solutions at HPLC 2017 105
Jun 05, 2017: Prosolia DESI 2D Molecular Imaging Now Compatible with Agilent Technologies 106
Oct 10, 2016: Agilent Technologies showcases innovative laboratory solutions at analytica China 2016 107
May 03, 2016: Agilent Technologies Introduces New Atomic Spectroscopy Platform for Multiple Analytical Applications 108
Apr 27, 2016: Agilent Technologies Statement – the Blueprint Project 109
Mar 09, 2016: Agilent Technologies Launches New Platform for Analyzing Cell-Free DNA 110
Jan 26, 2016: Agilent Technologies Showcases New Solutions at Biopharmaceutical Symposium 111
Other Significant Developments 112
Dec 21, 2016: Rubicon Genomics Signs Supply Agreement With Agilent Technologies For Its PicoPLEX WGA Kit 112
Oct 19, 2016: Jubilant Biosys Becomes the First Company in India to Install Agilent’s RapidFire/MS Screening Platform 113
Jul 28, 2016: Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research 114
Mar 14, 2016: Agilent Publishes Overview of Best Practices for Breast Cancer Diagnosis 115
Feb 11, 2016: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 116
Feb 11, 2016: TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 117
Jan 19, 2016: Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips 118
Appendix 119
Methodology 119
About GlobalData 119
Contact Us 119
Disclaimer 119

List of Tables
Agilent Technologies Inc, Medical Equipment, Key Facts, 2016 2
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Agilent Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Agilent Technologies Inc, Deals By Market, 2011 to YTD 2017 11
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies 16
Dako To Acquire Intellectual Property Rights From System Dynamics 17
NanoCellect Biomedical Raises USD10 Million in Series B Financing 18
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital 19
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection 20
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 21
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics 22
Agilent Technologies and Agendia Enter into Agreement 23
Agilent Technologies Enters into Agreement with Burning Rock Biotech 24
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging 25
Agilent Technologies Enters into Agreement with Eurofins Genomics 26
Agilent Technologies Enters into Agreement with 10X Genomics 27
Protea Biosciences Enters into Agreement with Agilent Technologies 28
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 29
Merck and Pfizer Enters into Agreement with Dako 30
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 31
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 32
Agilent Extends Co-Marketing Agreement with MRM Proteomics 33
Dako Enters into Agreement with Merck for Companion Diagnostic Test 34
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 35
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 36
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 37
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 38
Agilent Enters Into Research Agreement With Chungnam National University 39
Agilent Technologies Enters Into Co-Development Agreement With Florida International University 40
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics 41
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 42
Agilent Technologies Enters Into Research Agreement With Ameritox 43
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 44
Advion Enters Into Technology Integration Agreement With Agilent Technologies 45
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery 46
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics 47
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers 48
Dako Enters Into Co-Development Agreement With Amgen 49
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 50
Dako Enters Into Co-Development Agreement With Amgen 51
Dako Enters Into Co-Development Agreement With Bristol-Myers 52
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies 53
Dako Denmark Enters Into Co-Development Agreement With Epitomics 54
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 55
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 56
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 57
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026 58
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million 59
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 61
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 63
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies 64
Agilent Technologies Acquires Multiplicom for USD72 Million 65
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 66
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million 67
Agilent Technologies Acquires Cartagenia for USD68.34 Million 68
Agilent Technologies To Acquire ABC Instrumentacion Analitica 69
Leica Biosystems Completes Acquisition Of Aperio Technologies 70
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 72
Agilent Technologies Completes Acquisition Of BioSystem Development 74
Agilent Technologies Acquires P.V.R. 75
Agilent Technologies Acquires Lab901 76
Agilent Technologies Inc, Key Competitors 78
Agilent Technologies Inc, Key Employees 79
Agilent Technologies Inc, Subsidiaries 81

★海外企業調査レポート[Agilent Technologies Inc (A)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Harte Hanks Inc (HHS)：企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Acceleron Pharma Inc (XLRN)：企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Service Corporation International：企業の戦略・SWOT・財務情報
    Service Corporation International - Strategy, SWOT and Corporate Finance Report Summary Service Corporation International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • INRIX, Inc.：企業の戦略・SWOT・財務情報
    INRIX, Inc. - Strategy, SWOT and Corporate Finance Report Summary INRIX, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Habib’s：企業の戦略・SWOT・財務分析
    Habib's - Strategy, SWOT and Corporate Finance Report Summary Habib's - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • NextEra Energy Inc (NEE)：企業の財務・戦略的SWOT分析
    NextEra Energy Inc (NEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fosun International Ltd (656)：製薬・医療：M&Aディール及び事業提携情報
    Summary Fosun International Ltd (Fosun) is an investment holding company, which offers asset management, insurance, industrial operations and strategic investment services. The company, through its subsidiaries, manufactures and sells pharmaceutical and healthcare products; undertakes property devel …
  • Carraro Spa：戦略・SWOT・企業財務分析
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Venture Life Group Plc (VLG)-製薬・医療分野：企業M&A・提携分析
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The company's product range and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medica …
  • Wakefern Food Corp.：企業の戦略的SWOT分析
    Wakefern Food Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ultrastroy Eood：企業の戦略的SWOT分析
    Ultrastroy Eood - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Miraca Holdings Inc (4544)：製薬・医療：M&Aディール及び事業提携情報
    Summary Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early d …
  • Pousadas de Portugal：企業の戦略・SWOT・財務情報
    Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report Summary Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Retail Food Group Limited (Foodservice)：企業の戦略・SWOT・財務分析
    Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Xencor Inc (XNCR)：企業の財務・戦略的SWOT分析
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the …
  • Kumho Petrochemical Co Ltd (011780)：企業の財務・戦略的SWOT分析
    Kumho Petrochemical Co Ltd (011780) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BPH Energy Ltd (BPH)：企業の財務・戦略的SWOT分析
    BPH Energy Ltd (BPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • East Japan Railway Company：企業の戦略・SWOT・財務情報
    East Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • GE Lighting LLC：企業の戦略的SWOT分析
    GE Lighting LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sbarro, LLC：企業の戦略・SWOT・財務情報
    Sbarro, LLC - Strategy, SWOT and Corporate Finance Report Summary Sbarro, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆